Haemovigilance

Aim

improve safety for blood donors and transfusion recipients through promoting and supporting haemovigilance systems

Haemovigilance (HV) comprises surveillance procedures covering the whole transfusion chain from collection of blood (components) to follow-up of its recipients. It assesses information on undesirable transfusion effects to prevent their occurrence. This includes local venepuncture accidents, iron depletion, graft vs. host disease and mild to severe transfusion reactions. The HV definitions aim to standardize and report all these events in order to improve blood safety.

About

The WP focuses on both recipients and donors. We develop definitions and tools and share and compare data. We regularly discuss updates on international activities and work on definitions and tools. We collaborate with HV organisations across the world.

Our Chairperson is Kevin Land.

 

 

Activities

We meet at the ISBT congresses and develop HV definitions and tools. We also participate in international projects and have regular discussions with other Working Parties.

Joining the WP

Any professional who is actively involved in HV at any level is able to join this WP. Pharmaceutical company employees are able to join only if they contribute from a technical and scientific point of view, are transparent about their affiliation and do not promote any products.

Interested in joining the Haemovigilance WP? Please email our Chairperson.

 

 

MORE

Meetings

Some of the content is only accessible for ISBT-members. To join us, click here.

Watch the webcast Investigation and Management of non-infectious adverse transfusion reactions

Follow this link to visit the ISBT Academy ePortal and watch the webcast of Gwen Clarke. The talk was recorded at the 34th International Congress of the ISBT in Dubai. 

Other

Access the WHO Aide memoire on National Haemovigilance System here.

  1. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results Politis C. , Wiersum JC., Richardson C., Robillard P., Jorgensen J. , Renaudier P., Faber JC., Wood EM. Vox Sanguinis 2016 Nov; 111 (4): 409–417.
  2. Development of standard definitions for surveillance of complications related to blood donation. Goldman M, Land K, Robillard P, Wiersum-Osselton J. Vox Sang. 2015 Sept;110(2):185-8
  3. International survey on definitions and current practices in prevention, diagnosis, management and reporting of transfusion‐transmitted bacterial infections E. Chew R. J. Benjamin C. P. McDonald J. C. Wiersum‐Osselton E. M. Wood ISBT Science Series 2015 June, 10, 31–40, doi.org/10.1111/voxs.12176
  4. Donor vigilance: a global update J. C. Wiersum‐Osselton T. Marijt‐van der Kreek A. G. Bokhorst W. L. A. M. de Kort ISBT Science Series 2014 July, 9, 228–233, doi.org/10.1111/voxs.12090
  5. Haemovigilance: concepts and frameworks E. M. Wood L. Stevenson L. Bielby J. C. Wiersum‐Osselton ISBT Science Series 2014 July, 9, 86–90, doi.org/10.1111/voxs.12105
  6. Definitions in haemovigilance: guiding principles and current state of development of international reference definitions J. C. Wiersum‐Osselton E. Wood P. H. B. Bolton‐Maggs M. R. Schipperus ISBT Science Series 2014 July 9, 91–97, doi.org/10.1111/voxs.12091
  7. Donor vigilance: progress and challenges J. C. Wiersum‐Osselton T. Marijt‐van der Kreek W. L. A. M. de Kort ISBT Science Series 2012 June, 7: 251–255, doi.org/10.1111/j.1751-2824.2012.01588.x

2017 TACO Revised Reporting Criteria Validation exercise

2016 Donor Haemovigilance Case Validation Exercise

GET IN TOUCH

Kevin Land

Kevin Land

Chairperson

E-mail
Blood Systems
Fair Oaks Ranch
USA


OTHER WORKING PARTIES